In this issue:
- Announcing the 2015 CRN Scholars!
- Welcome New Investigators!
- Recent CRN-Related Publications
- Calls for Abstracts
- Additional Funding Opportunities
The Coordinating Center recently sent out the Opportunity Fund Call for Applications. In an effort to support project development, this solicitation is focused specifically on support of activities in the CRN setting that will result in submission of an R01 or similar application for grant funding. In past years, the CRN has sent out a Pilot and Developmental Projects Call for Applications. The Opportunity Fund mechanism is slightly different in that the scope of activities for any given project and application will be completed in a shorter time frame – on the order of a few months, with a maximum of 12 months, will be no more than $25,000 in direct cost, but preferably smaller, and will clearly define steps for and lay the ground work for submitting an R01 or similar grant.
For more information about the Opportunity Fund, including who can apply, evaluation criteria, and more, please email the CRN.
2014 Pilot Project Recipient Webinar
The current CRN Pilot Project PIs will participate in a webinar to talk about their progress and next steps. This webinar is scheduled for Friday, March 6, 11:00-1:00 PT. Please email the CRN for details on how to join.
- Gabriel Brooks, Dana Farber Cancer Institute
- Jason Lott, Yale University
- Carmit McMullen, KP Northwest
- Hazel Nichols, UNC Chapel Hill
- Pamala Pawloski, HealthPartners
- Dori Rosenberg, Group Health Cooperative
- Ramzi Salloum, University of South Carolina
Announcing the 2015 CRN Scholars!
We are pleased to announce the 2015-2017 cohort of CRN Scholars, and are looking forward to working with the new group over the next few years. Welcome to the CRN!
We would like to send a very sincere thank you to everyone who worked with the Scholar applicants to submit a competitive batch of applications, and also to those who participated in the review and selection process.
- Marie Bradley, PhD, MPH, Mpharm, National Cancer Institute. Testosterone therapy and prostate cancer risk and outcomes.
- Lisa Carter-Harris, PhD, RN, ANP-C, Indiana University School of Nursing. Prevalence of Lung Cancer Screening in High-Risk Smokers.
- Neetu Chawla, PhD, MPH, KP Northern California. Care coordination practices among HER 2+ breast cancer patients in an integrated delivery setting.
- Kim Danforth, ScD, MPH, KP Southern California. Bladder cancer care.
- Sara Javid, MD, University of Washington. Development of a Predictive Tool to Estimate Individualized Cancer Recurrence Risk Following Treatment of Ductal Carcinoma in Situ (DCIS).
- Elizabeth Kantor, PhD, MPH, Harvard School of Public Health. Obesity and Breast Cancer Survival: The Role of Chemotherapy Dosing.
- Whitney Robinson, PhD, MSPH, UNC Gillings School of Global Public Health. Trends in surgical menopause and implications for breast cancer disparities: a pilot study of data from KPNC.
- Ramzi Salloum, PhD, MA, MBA, Arnold School of Public Health University of South Carolina. Measuring individual patient preferences for management of prostate cancer.
- Ravi Sharaf, MD, MS, North Shore-Long Island Jewish Health System. Identification of a Lynch Syndrome Cohort within the Cancer Research Network.
- Andy Tan, PhD, MPH, MBA, MBBS, Dana-Farber Cancer Insitute, Harvard Medical School. Role of Patient-Centered Communication in Improving Adherence to Recommended Intervals of Colonoscopy Surveillance After Polypectomy.
Welcome New Investigators!
Andrea Burnett-Hartman, PhD has been appointed as an Investigator at KPCO's Institute for Health Research.
Andrea joins KPCO from the Fred Hutchinson Cancer Research Center and the University of Washington. Her research focuses on understanding factors associated with colorectal cancer, precursor lesions, and colorectal cancer screening. Her current research is aimed at understanding the clinical importance of subsets of serrated polyps, with the ultimate goal of defining the risk of colorectal cancer in those with different types of serrated polyps and improving the effectiveness of colorectal cancer screening and surveillance. She is also a co-investigator at the coordinating center for the NIH-sponsored multi-site initiative, Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) and is collaborating with other KP Investigators on KP’s multi-site Research Bank initiative.
Neetu Chawla, PhD, MPH is a new Investigator at KP Northern California's Division of Research.
Neetu joins KPNC from the National Cancer Institute, where she completed a three-year postdoctoral fellowship as a Cancer Prevention Fellow. Neetu received her PhD in Health Services Research and MPH in Community Health Sciences from the UCLA Fielding School of Public Health. Her research focuses on quality of cancer care delivery and specifically on patient-provider communication, patterns of care delivery, care coordination, and cancer survivorship care. She is currently a co-Investigator on three KPNC grants: the first with Laurie Habel focusing on cardiotoxicity among HER2+ breast cancer patients, the second with Alyce Adams focusing on the impact of the Affordable Care Act on utilization of general and preventive services among KPNC patients, and the third with Richard Grant on aligning priorities between patients with multiple chronic conditions and their primary care providers.
Recent CRN-Related Publications
Lee JK, Jensen CD, Lee A, Doubeni CA, Zauber AG, Levin TR, Zhao WK, Corley DA. Development and validation of an algorithm for classifying colonoscopy indication. Gastrointest Endosc 2015 Jan 8. pii: S0016-5107(14)01980-4. [Epub ahead of print] [View Abstract]
Henderson LM, O'Meara ES, Braithwaite D, Onega T; for the Breast Cancer Surveillance Consortium. Performance of digital screening mammography among older women in the United States. Cancer 2014 Dec 23. [Epub ahead of print] [View Abstract]
Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS, de Koning HJ, Kerlikowske K, Lehman CD, Tosteson AN. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med 2015 Feb 3;162(3):157-66. doi: 10.7326/M14-0692. [View Abstract]
Jensen CD, Doubeni CA, Quinn VP, Levin TR, Zauber AG, Schottinger JE, Marks AR, Zhao WK, Lee JK, Ghai NR, Schneider JL, Fireman BH, Quesenberry CP, Corley DA. Adjusting for Patient Demographics Has Minimal Effects on Rates of Adenoma Detection in a Large, Community-based Setting. Clin Gastroenterol Hepatol 2014 Oct 25. pii: S1542-3565(14)01569-9. [Epub ahead of print] [View Abstract]
Rabin BA, Ellis JL, Steiner JF, Nekhlyudov L, Feuer EJ, Hankey BF, Cynkin L, Bayliss E. Health-care utilization by prognosis profile in a managed care setting: using the Surveillance, Epidemiology and End Results Cancer Survival Calculator SEER*CSC. J Natl Cancer Inst Monogr 2014 Nov;2014(49):275-81. doi: 10.1093/jncimonographs/lgu023. [View Abstract]
Hornbrook MC, Malin J, Weeks JC, Makgoeng SB, Keating NL, Potosky AL. Did changes in drug reimbursement after the medicare modernization act affect chemotherapy prescribing? J Clin Oncol 2014 Dec 20;32(36):4042-9. [View Abstract]
Han PK, Williams AE, Haskins A, Gutheil C, Lucas FL, Klein WM, Mazor KM. Individual differences in aversion to ambiguity regarding medical tests and treatments: association with cancer screening cognitions. Cancer Epidemiol Biomarkers Prev 2014 Dec;23(12):2916-23. [View Abstract]
Resnicow K, Zhou Y, Hawley S, Jimbo M, Ruffin MT, Davis RE, Shires D, Lafata JE. Communication preference moderates the effect of a tailored intervention to increase colorectal cancer screening among African Americans. Patient Educ Couns 2014 Dec;97(3):370-5. [View Abstract]
Chrischilles EA, McDowell BD, Rubenstein L, Charlton M, Pendergast J, Juarez GY, Arora NK. Survivorship care planning and its influence on long-term patient-reported outcomes among colorectal and lung cancer survivors: the CanCORS disease-free survivor follow-up study. J Cancer Surviv 2014 Oct 30. [Epub ahead of print] [View Abstract]
Calls for Abstracts
2015 APHA Annual Meeting and Exposition, Cancer Forum - Abstracts due February 10, 2015
Additional Funding Opportunities
NCI-funded Post-Doctoral Training Opportunity in Implementation Science
Application deadline February 15, 2015
PRACCTIS is a full-time NCI-funded post-doctoral fellowship training program designed to provide the next generation of cancer prevention and control researchers with the knowledge and skill sets to eliminate gaps in the translation of research to practice along the cancer continuum, including prevention of disease, early detection, diagnosis, treatment and survivorship.
This 2-3 year program emphasizes didactic training in implementation science and mentored research opportunities and provides access to a wide array of training and enrichment opportunities on the UMass Medical School campus. We emphasize training independent investigators who will become leaders in cancer prevention and control implementation science research.
Empirical Research on Ethical Issues Related to Central IRBs and Consent for Research Using Clinical Records and Data (R01). (RFA-OD-15-002)
Applications due February 19, 2015
Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment (R01). (PAR-15-075)
Applications due March 6, 2015
Copyright © 2015 The Cancer Research Network, All rights reserved.